Faculty
|
Dr. Stefano Barco
Stefano Barco is an internist and vascular medicine specialist working as staff physician and head of research at the Department of Angiology of the University Hospital Zurich, Switzerland. He is active in the acute and long-term care of patients with pulmonary embolism, also including novel endovascular strategies. He has written or co-authored 150 articles in peer-reviewed journals primarily focusing on the epidemiology and management of pulmonary embolism. He is a member of the World Thrombosis Day steering committee, in the nucleus of the European Society of Cardiology "Working Group on Pulmonary Circulation and Right Ventricular Function", co-chair of the International Society on Thrombosis and Hemostasis subcommittee "Factor XI and the Contact System", and has editorial duties in several scientific journals in the field.
|
|
|
Dr. Laurent Bertoletti
Laurent Bertoletti is Medical Doctor and Professor of Medicine in the University Hospital of St-Etienne (CHUSE), France.
He graduated as a chest physician in the faculty of Medicine of St-Etienne, France.
After a fellowship in the department of Pr Gerald SIMONNEAU (Paris), he created and developed the pulmonary hypertension program of the University Hospital of St-Etienne.
After a post-doc in the "Angiology and Haemostasis" department of Pr H BOUNAMEAUX (Geneva, Switzerland), he moved to the Vascular Medicine department of the CHUSE, the department he leads for several years.
His current researches focus on the management of vascular diseases, with specific attention to anticoagulant therapy in patients with pulmonary vascular diseases. He is highly involved in clinical research in venous thromboembolism, with interaction in basic sciences
He is the national coordinator of the RIETE registry, and the co-coordinator of the French INNOVTE network (with Pr Francis COUTURAUD, Brest, France).
In 2021, he has been elected chairman of the "Pulmonary Embolism" sub-assemble of the European Respiratory Society, a large scientific society, which spans over 160 countries, prioritizing science, education and advocacy to promote lung health. He authored more than 250 references on Pubmed.
|
|
|
Dr. Hobohm
The scientific focus of Dr. Hobohm is on optimizing risk stratification and management strategies for patients with acute pulmonary embolism. In this context Dr. Hobohm also focusing on epidemiological as well as translational "bench-to-bedside" research of thombotic and thromboembolic disorders. Furthermore Dr. Hobohm is working as a senior physician at the Department of Cardiology at the Medical University in Mainz and is supporting as a clinical investigator ongoing prospective cohort studies and interventional trials at the the Center for Thrombosis and Hemostasis (CTH) in Mainz.
|
|
|
Prof. Menno Huisman
Menno Huisman, MD, PhD, FESC, is internist and registrar in cardiovascular medicine and full professor in the Department of Medicine - Thrombosis and Hemostasis at the Leiden University Medical Center.
Dr Huisman's main research areas are in clinical research, particularly in the areas of diagnosis and treatment of venous and arterial thromboembolism.
He is the European representative in the Board of Directors of the United States based PERT organisation.
|
|
|
Prof. Erik Klok
Prof. F.A. (Erik) Klok is a board-certified specialist in Internal Medicine, with a specialty in vascular medicine in the Leiden University Medical Center (Leiden, the Netherlands) and holds a position as visiting professor at the Center for thrombosis and Hemostasis in Mainz (Germany). This allows him to combine clinical work with scientific activities. His research interests include the diagnosis, treatment and long-term complications of venous thromboembolism.
|
|
|
Prof. Stavros Konstantinides
Stavros Konstantinides is Professor for Clinical Trials and Medical Director of the multidisciplinary Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. He is also Professor of Cardiology at the Democritus University of Thrace, Greece. He completed his clinical training in Cardiology and gained his doctorate thesis at the University of Freiburg, Germany. He has worked as Consultant Cardiologist, Assistant and Associate Professor of Medicine at the Universities of Freiburg and Goettingen, Germany, and as Research Associate and Visiting Scientist at the Department of Vascular Biology, the Scripps Research Institute, La Jolla, CA, USA. For the past 32 years, his research has focused on the pathomechanisms of thrombosis, and on the risk stratification and risk-adapted antithrombotic management of pulmonary embolism. He has designed and coordinated, or has been principal investigator of several guidelines-relevant multinational trials which have been published in high-impact journals. His research is funded by national and European peer-reviewed granting agencies. He is leading member of national and European committees, task forces for international guidelines, and networks focusing on the pulmonary circulation and right ventricular function.
|
|
|
Prof. Irene Lang
Irene M Lang is a clinical cardiologist and Professor of Vascular Biology at the Medical University of Vienna. She has been nominated as one of the WMA-Caring Physicians of the World in 2005. She directs an out-patient clinic for pulmonary vascular diseases and is an active interventional and structural cardiologist. She also leads basic research on the biology of vascular occlusions, with a special focus on chronic thromboembolic pulmonary hypertension. Prof. Lang is a Member of the Austrian and European societies of cardiology, member of senate of the Medical University of Vienna and Editor for Pulmonary Circulation, the European Heart Journal and Atherosclerosis.
|
|
|
Prof. Nicolas Meneveau
Prof. Nicolas Meneveau is Chief of the Heart-Lung Division and Head of the hemodynamics and interventional cardiology unit at the University Hospital of Besançon (France). He is in charge of venous thromboembolic diseases and has been actively involved in development of guidelines for the management of cardiological emergencies. In his professional career, he has focused extensive work on venous thrombo-embolic disease, particularly on thrombolysis in high risk PE. Professor Meneveau is a member of different professional societies, including the French Society of Cardiology, and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
|
|
|
Dr. Lilian Meijboom
Lilian Meijboom is a cardiothoracic radiologist working in the AUMC, Amsterdam, The Netherlands, specialized in pulmonary vascular disease, interstitial lung disease and pulmonary hypertension. She is president of the section Thoracic Radiology of the Dutch Radiology Society and member of the pulmonary embolic rescue team (PERT) in her hospital. The last years she used advanced CTPA and cardiac MRI techniques for early identification of Chronic Tromboembolic Pulmonary Hypertension (CTEPH) patients, better understanding the different phases of pulmonary thromboembolic lesions and evaluating the role of the right ventricle in CTEPH.
|
|
|
Dr. Jose Montero Cabezas
Interventional cardiologist at the Leiden University Medical Center (The Netherlands), with broad experience in complex high-risk coronary procedures, structural heart interventions and mechanical circulatory support in cardiogenic shock. He is co-founder and core member of the local pulmonary embolism response team (ALERT), with focus in invasive therapeutic strategies in patients with pulmonary embolism.
|
|
|
Prof. Fionnuala Ní Ainle
Fionnuala Ní Ainle is a Consultant Haematologist at the Mater Misericordiae University Hospital (MMUH) and Rotunda Maternity Hospital, Dublin, Ireland. She is Full Clinical Professor, University College Dublin (UCD) School of Medicine. She is privileged to treat patients affected with Venous Thromboembolism (VTE) and has a strong interest in women’s issues in thrombosis and haemostasis. Prof. Ní Áinle serves as Director of the Irish Network for VTE Research and with Prof. Patricia Maguire, co-directs the SPHERE Research Group, UCD Conway Institute. She is honoured to work very closely with the Irish patient organization Thrombosis Ireland, raising VTE awareness in Ireland and internationally. She is actively involved in international VTE clinical trials and serves on several trial steering committees. Her translational research interests explore the role of blood coagulation and extracellular vesicles in the aetiology, management and therapy of clinical disorders, particularly disorders of pregnancy. She is a former member of the World Thrombosis Day International Steering Committee and serves as a council member and “director at large” of INVENT-VTE (the International Network of VENous Thromboembolism Clinical Research Networks). She acted as a Section Coordinator on the Task Force of the 2019 European Society of Cardiology (ESC) Guidelines on the diagnosis and management of acute Pulmonary Embolism and serves on the editorial board of several journals, including the Journal of Thrombosis and Haemostasis.
|
|
|
Prof. Piotr Pruszczyk
Head of Dept. of Internal Medicine and Cardiology, Medical University of Warsaw.
Main research areas:
Assessment of echocardiography and CTPA in diagnosis of acute pulmonary embolism (PE),
Role of biomarkers and echocardiography in risk stratification of patients with acute PE,
Diagnosis and treatment CTEPH,
Cardiovascular complication of musculoskeletal diseases,
|
|
|
Dr. Andrew Sharp
Dr Andrew SP Sharp qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff, UK in the summer of 2019.
He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo.
Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, catheter-directed treatments for pulmonary embolism, intracoronary imaging and coronary physiology.
He is a member of the executive committee of the HI PEITHO randomised controlled trial of catheter-directed lysis vs anticoagulation in patients with intermediate-high risk pulmonary embolism.
|
|
|
|
